TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9302065
log Bayes Factor = 0.280585
Chromosome 13   position 95,971,016  (GRCh37) Explore rs9302065 on Ensembl!
Variant rs9302065 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
R33 Retention of urine
0.280 0.720 0.000
B07 Viral warts
0.259 0.741 0.000
A04.8 Other specified bacterial intestinal infections
0.093 0.907 0.000
C01 Malignant neoplasm of base of tongue
0.000 0.936 0.064
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.000 0.956 0.044
C02 Malignant neoplasm of other and unspecified parts of tongue
0.000 0.960 0.040
A04 Other bacterial intestinal infections
0.039 0.961 0.000
C07 Malignant neoplasm of parotid gland
0.000 0.963 0.037
C10 Malignant neoplasm of oropharynx
0.000 0.963 0.037
C02.9 Tongue, unspecified
0.000 0.963 0.037
C02.4 Lingual tonsil
0.000 0.963 0.036
C09 Malignant neoplasm of tonsil
0.000 0.964 0.036
R80 Isolated proteinuria
0.035 0.965 0.000
A04.5 Campylobacter enteritis
0.034 0.966 0.000
C11 Malignant neoplasm of nasopharynx
0.000 0.967 0.032
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.032 0.968 0.000
C10.9 Oropharynx, unspecified
0.000 0.968 0.032
C06 Malignant neoplasm of other and unspecified parts of mouth
0.000 0.968 0.032
L40.5 Arthropathic psoriasis
0.000 0.969 0.031
C12 Malignant neoplasm of pyriform sinus
0.000 0.969 0.031
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.000 0.969 0.031
C03 Malignant neoplasm of gum
0.000 0.969 0.031
C13 Malignant neoplasm of hypopharynx
0.000 0.970 0.030
C09.9 Tonsil, unspecified
0.000 0.970 0.030
C02.8 Overlapping lesion of tongue
0.000 0.971 0.029
C02.3 Anterior two-thirds of tongue, part unspecified
0.000 0.971 0.029
C02.0 Dorsal surface of tongue
0.000 0.971 0.029
C00 Malignant neoplasm of lip
0.000 0.971 0.029
C09.1 Tonsillar pillar (anterior) (posterior)
0.000 0.971 0.029
L40.0 Psoriasis vulgaris
0.000 0.971 0.029
L40 Psoriasis
0.000 0.972 0.028
A04.6 Enteritis due to Yersinia enterocolitica
0.028 0.972 0.000
A04.3 Enterohaemorrhagic Escherichia coli infection
0.028 0.972 0.000
A04.2 Enteroinvasive Escherichia coli infection
0.028 0.972 0.000
A04.1 Enterotoxigenic Escherichia coli infection
0.028 0.972 0.000
A04.0 Enteropathogenic Escherichia coli infection
0.028 0.972 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.000 0.972 0.028
C04 Malignant neoplasm of floor of mouth
0.000 0.972 0.027
C02.1 Border of tongue
0.000 0.973 0.027
C10.8 Overlapping lesion of oropharynx
0.000 0.973 0.027
C10.4 Branchial cleft
0.000 0.973 0.027
C10.3 Posterior wall of oropharynx
0.000 0.973 0.027
C10.2 Lateral wall of oropharynx
0.000 0.973 0.027
C10.1 Anterior surface of epiglottis
0.000 0.973 0.027
C10.0 Vallecula
0.000 0.973 0.027
A04.9 Bacterial intestinal infection, unspecified
0.026 0.973 0.000
C05 Malignant neoplasm of palate
0.000 0.974 0.026
C09.8 Overlapping lesion of tonsil
0.000 0.974 0.026
C06.2 Retromolar area
0.000 0.975 0.025
A04.4 Other intestinal Escherichia coli infections
0.025 0.975 0.000
C09.0 Tonsillar fossa
0.000 0.975 0.025
L40.3 Pustulosis palmaris et plantaris
0.000 0.976 0.024
B01 Varicella [chickenpox]
0.024 0.976 0.000
C11.9 Nasopharynx, unspecified
0.000 0.976 0.024
C11.8 Overlapping lesion of nasopharynx
0.000 0.976 0.023
C11.3 Anterior wall of nasopharynx
0.000 0.976 0.023
C11.2 Lateral wall of nasopharynx
0.000 0.976 0.023
C11.1 Posterior wall of nasopharynx
0.000 0.976 0.023
C11.0 Superior wall of nasopharynx
0.000 0.976 0.023
C03.1 Lower gum
0.000 0.977 0.023
B06 Rubella [German measles]
0.023 0.977 0.000
B05 Measles
0.023 0.977 0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions
0.023 0.977 0.000
B04 Monkeypox
0.023 0.977 0.000
B03 Smallpox
0.023 0.977 0.000
C03.9 Gum, unspecified
0.000 0.977 0.023
C06.8 Overlapping lesion of other and unspecified parts of mouth
0.000 0.977 0.023
C06.1 Vestibule of mouth
0.000 0.977 0.023
C02.2 Ventral surface of tongue
0.000 0.977 0.022
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.000 0.977 0.022
C14.2 Waldeyer's ring
0.000 0.977 0.022
C06.9 Mouth, unspecified
0.000 0.978 0.022
C14.0 Pharynx, unspecified
0.000 0.978 0.022
L40.1 Generalised pustular psoriasis
0.000 0.978 0.022
C13.8 Overlapping lesion of hypopharynx
0.000 0.978 0.021
C13.2 Posterior wall of hypopharynx
0.000 0.978 0.021
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.000 0.978 0.021
C13.0 Postcricoid region
0.000 0.978 0.021
L40.4 Guttate psoriasis
0.000 0.979 0.021
C00.8 Overlapping lesion of lip
0.000 0.979 0.021
C00.6 Commissure of lip
0.000 0.979 0.021
C00.5 Lip, unspecified, inner aspect
0.000 0.979 0.021
C00.4 Lower lip, inner aspect
0.000 0.979 0.021
C00.3 Upper lip, inner aspect
0.000 0.979 0.021
C00.2 External lip, unspecified
0.000 0.979 0.021
C00.1 External lower lip
0.000 0.979 0.021
L40.2 Acrodermatitis continua
0.000 0.979 0.020
C06.0 Cheek mucosa
0.000 0.980 0.020
C08.8 Overlapping lesion of major salivary glands
0.000 0.980 0.020
C08.1 Sublingual gland
0.000 0.980 0.020
C00.9 Lip, unspecified
0.000 0.980 0.020
C04.8 Overlapping lesion of floor of mouth
0.000 0.980 0.020
C04.1 Lateral floor of mouth
0.000 0.980 0.020
C00.0 External upper lip
0.000 0.980 0.019
Z43.3 Attention to colostomy
0.020 0.980 0.000
C13.9 Hypopharynx, unspecified
0.000 0.980 0.019
C05.9 Palate, unspecified
0.000 0.980 0.019
C03.0 Upper gum
0.000 0.981 0.019
C05.8 Overlapping lesion of palate
0.000 0.981 0.019
C05.2 Uvula
0.000 0.981 0.019
C08.0 Submandibular gland
0.000 0.981 0.019
J31.0 Chronic rhinitis
0.019 0.981 0.000
L40.8 Other psoriasis
0.000 0.981 0.019
C04.9 Floor of mouth, unspecified
0.000 0.981 0.018
B01.8 Varicella with other complications
0.018 0.982 0.000
B01.2 Varicella pneumonia
0.018 0.982 0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified
0.018 0.982 0.000
C08.9 Major salivary gland, unspecified
0.000 0.982 0.018
R80-R82 Abnormal findings on examination of urine, without diagnosis
0.018 0.982 0.000
B01.1 Varicella encephalitis
0.017 0.982 0.000
B01.0 Varicella meningitis
0.017 0.982 0.000
C04.0 Anterior floor of mouth
0.000 0.983 0.017
L40-L45 Papulosquamous disorders
0.000 0.983 0.017
B05.9 Measles without complication
0.017 0.983 0.000
B05.8 Measles with other complications
0.017 0.983 0.000
B05.4 Measles with intestinal complications
0.017 0.983 0.000
B05.3 Measles complicated by otitis media
0.017 0.983 0.000
B05.2 Measles complicated by pneumonia
0.017 0.983 0.000
B05.1 Measles complicated by meningitis
0.017 0.983 0.000
B05.0 Measles complicated by encephalitis
0.017 0.983 0.000
B06.9 Rubella without complication
0.017 0.983 0.000
B06.8 Rubella with other complications
0.017 0.983 0.000
B06.0 Rubella with neurological complications
0.017 0.983 0.000
B01.9 Varicella without complications
0.017 0.983 0.000
C05.0 Hard palate
0.000 0.983 0.017
B02 Zoster [herpes zoster]
0.016 0.984 0.000
C05.1 Soft palate
0.000 0.984 0.016
R82.9 Other and unspecified abnormal finding in urine
0.016 0.984 0.000
R82 Other abnormal findings in urine
0.016 0.984 0.000
L93.0 Discoid lupus erythematosus
0.000 0.984 0.016
L43 Lichen planus
0.000 0.984 0.015
A00-A09 Intestinal infectious diseases
0.015 0.985 0.000
L43.9 Lichen planus, unspecified
0.000 0.986 0.014
A04.7 Enterocolitis due to Clostridium difficile
0.014 0.986 0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions
0.013 0.987 0.000
B08.5 Enteroviral vesicular pharyngitis
0.013 0.987 0.000
B08.4 Enteroviral vesicular stomatitis with exanthem
0.013 0.987 0.000
B08.3 Erythema infectiosum [fifth disease]
0.013 0.987 0.000
B08.2 Exanthema subitum [sixth disease]
0.013 0.987 0.000
B08.0 Other orthopoxvirus infections
0.013 0.987 0.000
R82.1 Myoglobinuria
0.013 0.987 0.000
Y40.9 Systemic antibiotic, unspecified
0.013 0.987 0.000
L41 Parapsoriasis
0.000 0.987 0.013
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.987 0.012
J30.1 Allergic rhinitis due to pollen
0.013 0.987 0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances
0.012 0.988 0.000
L43.8 Other lichen planus
0.000 0.988 0.012
L42 Pityriasis rosea
0.000 0.988 0.012
A09 Diarrhoea and gastro-enteritis of presumed infectious origin
0.012 0.988 0.000
L44 Other papulosquamous disorders
0.000 0.988 0.012
B02.7 Disseminated zoster
0.012 0.988 0.000
B02.0 Zoster encephalitis
0.012 0.988 0.000
B02.2 Zoster with other nervous system involvement
0.012 0.988 0.000
B02.8 Zoster with other complications
0.012 0.988 0.000
B00 Herpesviral [herpes simplex] infections
0.012 0.988 0.000
A06 Amoebiasis
0.012 0.988 0.000
A09.9 Gastroenteritis and colitis of unspecified origin
0.012 0.988 0.000
C71.9 Brain, unspecified
0.012 0.988 0.000
A05 Other bacterial foodborne intoxications
0.012 0.988 0.000
C71 Malignant neoplasm of brain
0.012 0.988 0.000
B02.3 Zoster ocular disease
0.011 0.988 0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source
0.011 0.989 0.000
R82.3 Haemoglobinuria
0.011 0.989 0.000
R82.2 Biliuria
0.011 0.989 0.000
R82.0 Chyluria
0.011 0.989 0.000
L43.3 Subacute (active) lichen planus
0.000 0.989 0.011
L43.2 Lichenoid drug reaction
0.000 0.989 0.011
L43.1 Bullous lichen planus
0.000 0.989 0.011
B02.1 Zoster meningitis
0.011 0.989 0.000
C71.2 Temporal lobe
0.011 0.989 0.000
A03 Shigellosis
0.011 0.989 0.000
Y40 Systemic antibiotics
0.011 0.989 0.000
D73.0 Hyposplenism
0.000 0.989 0.011
A07 Other protozoal intestinal diseases
0.011 0.989 0.000
A01 Typhoid and paratyphoid fevers
0.011 0.989 0.000
A00 Cholera
0.011 0.989 0.000
R81 Glycosuria
0.011 0.989 0.000
Y40.3 Macrolides
0.011 0.989 0.000
L43.0 Hypertrophic lichen planus
0.000 0.989 0.011
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.011 0.989 0.000
C71.4 Occipital lobe
0.010 0.989 0.000
C71.1 Frontal lobe
0.010 0.990 0.000
J30.4 Allergic rhinitis, unspecified
0.010 0.990 0.000
J30 Vasomotor and allergic rhinitis
0.010 0.990 0.000
Y44.2 Anticoagulants
0.010 0.990 0.000
L41.1 Pityriasis lichenoides chronica
0.000 0.990 0.010
A06.4 Amoebic liver abscess
0.009 0.990 0.000
B00.0 Eczema herpeticum
0.009 0.990 0.000
L41.9 Parapsoriasis, unspecified
0.000 0.990 0.009
L41.8 Other parapsoriasis
0.000 0.990 0.009
L41.5 Retiform parapsoriasis
0.000 0.990 0.009
L41.4 Large plaque parapsoriasis
0.000 0.990 0.009
L41.3 Small plaque parapsoriasis
0.000 0.990 0.009
L41.2 Lymphomatoid papulosis
0.000 0.990 0.009
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.990 0.009
B00.3 Herpesviral meningitis
0.009 0.991 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.009 0.991 0.000
A05.9 Bacterial foodborne intoxication, unspecified
0.009 0.991 0.000
R82.4 Acetonuria
0.009 0.991 0.000
R82.7 Abnormal findings on microbiological examination of urine
0.009 0.991 0.000
L44.9 Papulosquamous disorder, unspecified
0.000 0.991 0.009
L44.8 Other specified papulosquamous disorders
0.000 0.991 0.009
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.991 0.009
L44.3 Lichen ruber moniliformis
0.000 0.991 0.009
L44.2 Lichen striatus
0.000 0.991 0.009
L44.1 Lichen nitidus
0.000 0.991 0.009
B00.8 Other forms of herpesviral infection
0.009 0.991 0.000
C71.7 Brain stem
0.009 0.991 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
B00.4 Herpesviral encephalitis
0.009 0.991 0.000
B00.7 Disseminated herpesviral disease
0.008 0.991 0.000
Y40.4 Tetracyclines
0.009 0.991 0.000
A06.9 Amoebiasis, unspecified
0.009 0.991 0.000
A06.8 Amoebic infection of other sites
0.009 0.991 0.000
A06.7 Cutaneous amoebiasis
0.009 0.991 0.000
A06.6 Amoebic brain abscess
0.009 0.991 0.000
A06.5 Amoebic lung abscess
0.009 0.991 0.000
A06.3 Amoeboma of intestine
0.009 0.991 0.000
A06.2 Amoebic nondysenteric colitis
0.009 0.991 0.000
A06.1 Chronic intestinal amoebiasis
0.009 0.991 0.000
A06.0 Acute amoebic dysentery
0.009 0.991 0.000
Y44 Agents primarily affecting blood constituents
0.009 0.991 0.000
C71.6 Cerebellum
0.009 0.991 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.009 0.991 0.000
C71.8 Overlapping lesion of brain
0.009 0.991 0.000
C71.5 Cerebral ventricle
0.009 0.991 0.000
Y42.5 Other oestrogens and progestogens
0.009 0.991 0.000
A05.8 Other specified bacterial foodborne intoxications
0.008 0.991 0.000
A05.4 Foodborne Bacillus cereus intoxication
0.008 0.991 0.000
A05.3 Foodborne Vibrio parahaemolyticus intoxication
0.008 0.991 0.000
A05.2 Foodborne Clostridium perfringens [Clostridium welchii] intoxication
0.008 0.991 0.000
A05.1 Botulism
0.008 0.991 0.000
A05.0 Foodborne staphylococcal intoxication
0.008 0.991 0.000
L44.0 Pityriasis rubra pilaris
0.000 0.991 0.008
Y40.8 Other systemic antibiotics
0.009 0.991 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.009 0.991 0.000
B08.1 Molluscum contagiosum
0.008 0.992 0.001
Y40.0 Penicillins
0.008 0.992 0.000
A03.9 Shigellosis, unspecified
0.008 0.992 0.000
Y52 Agents primarily affecting the cardiovascular system
0.008 0.992 0.000
A03.8 Other shigellosis
0.008 0.992 0.000
A03.3 Shigellosis due to Shigella sonnei
0.008 0.992 0.000
A03.2 Shigellosis due to Shigella boydii
0.008 0.992 0.000
A03.1 Shigellosis due to Shigella flexneri
0.008 0.992 0.000
A03.0 Shigellosis due to Shigella dysenteriae
0.008 0.992 0.000
Y40.2 Chloramphenicol group
0.008 0.992 0.000
A07.1 Giardiasis [lambliasis]
0.008 0.992 0.000
A07.9 Protozoal intestinal disease, unspecified
0.008 0.992 0.000
A07.8 Other specified protozoal intestinal diseases
0.008 0.992 0.000
A07.3 Isosporiasis
0.008 0.992 0.000
A07.2 Cryptosporidiosis
0.008 0.992 0.000
A07.0 Balantidiasis
0.008 0.992 0.000
Y53.4 Other laxatives
0.008 0.992 0.000
A00.9 Cholera, unspecified
0.008 0.992 0.000
A00.1 Cholera due to Vibrio cholerae 01, biovar el tor
0.008 0.992 0.000
A00.0 Cholera due to Vibrio cholerae 01, biovar cholerae
0.008 0.992 0.000
A01.4 Paratyphoid fever, unspecified
0.008 0.992 0.000
A01.3 Paratyphoid fever C
0.008 0.992 0.000
A01.2 Paratyphoid fever B
0.008 0.992 0.000
A01.1 Paratyphoid fever A
0.008 0.992 0.000
A01.0 Typhoid fever
0.008 0.992 0.000
A02 Other Salmonella infections
0.008 0.992 0.000
J31.2 Chronic pharyngitis
0.008 0.992 0.000
Y40.5 Aminoglycosides
0.008 0.992 0.000
Y40.6 Rifamycins
0.008 0.992 0.000
A08 Viral and other specified intestinal infections
0.008 0.992 0.000
C71.3 Parietal lobe
0.008 0.992 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.008 0.992 0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis
0.007 0.992 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.008 0.992 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.008 0.992 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.008 0.992 0.000
B02.9 Zoster without complication
0.008 0.992 0.000
Y42.1 Thyroid hormones and substitutes
0.007 0.992 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.007 0.992 0.000
Y40.7 Antifungal antibiotics, systemically used
0.007 0.993 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.007 0.993 0.000
D73 Diseases of spleen
0.000 0.993 0.007
Y52.3 Coronary vasodilators, not elsewhere classified
0.007 0.993 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.007 0.993 0.000
J30.2 Other seasonal allergic rhinitis
0.007 0.993 0.000
J30.0 Vasomotor rhinitis
0.007 0.993 0.000
C71.0 Cerebrum, except lobes and ventricles
0.007 0.993 0.000
Y49.5 Other antipsychotics and neuroleptics
0.007 0.993 0.000
B00.1 Herpesviral vesicular dermatitis
0.007 0.993 0.000
Y58 Bacterial vaccines
0.007 0.993 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.007 0.993 0.000
Y59 Other and unspecified vaccines and biological substances
0.007 0.993 0.000
Y53.6 Antidiarrhoeal drugs
0.007 0.993 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.007 0.993 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.007 0.993 0.000
B00.5 Herpesviral ocular disease
0.006 0.993 0.000
Y52.1 Calcium-channel blockers
0.007 0.993 0.000
Y42.9 Other and unspecified hormone antagonists
0.007 0.993 0.000
Y53.2 Stimulant laxatives
0.007 0.993 0.000
L93 Lupus erythematosus
0.000 0.993 0.007
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.007 0.993 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.007 0.993 0.000
D73.9 Disease of spleen, unspecified
0.000 0.993 0.007
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.993 0.000
Y53.7 Emetics
0.006 0.993 0.000
Y53.5 Digestants
0.006 0.993 0.000
Y53.3 Saline and osmotic laxatives
0.006 0.993 0.000
Y53.0 Histamine H2-receptor antagonists
0.006 0.993 0.000
J31.1 Chronic nasopharyngitis
0.006 0.993 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.006 0.993 0.000
A08.1 Acute gastro-enteropathy due to Norwalk agent
0.007 0.993 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.006 0.993 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.006 0.993 0.000
Y44.7 Plasma substitutes
0.006 0.993 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.006 0.993 0.000
Y44.6 Natural blood and blood products
0.006 0.994 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.006 0.994 0.000
Y46.5 Valproic acid
0.006 0.994 0.000
Y46.4 Iminostilbenes
0.006 0.994 0.000
A08.5 Other specified intestinal infections
0.006 0.994 0.000
Y48 Anaesthetics and therapeutic gases
0.006 0.994 0.000
Y42.2 Antithyroid drugs
0.006 0.994 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.006 0.994 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.006 0.994 0.000
Z43 Attention to artificial openings
0.006 0.994 0.000
Y47.1 Benzodiazepines
0.006 0.994 0.000
R82.8 Abnormal findings on cytological and histological examination of urine
0.006 0.994 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.006 0.994 0.000
A02.8 Other specified Salmonella infections
0.006 0.994 0.000
A02.2 Localised Salmonella infections
0.006 0.994 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.006 0.994 0.000
J30-J39 Other diseases of upper respiratory tract
0.006 0.994 0.000
D73.3 Abscess of spleen
0.000 0.994 0.006
D73.1 Hypersplenism
0.000 0.994 0.006
Y52.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
A08.2 Adenoviral enteritis
0.006 0.994 0.000
A08.0 Rotaviral enteritis
0.006 0.994 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.006 0.994 0.000
A02.9 Salmonella infection, unspecified
0.006 0.994 0.000
Y46.2 Hydantoin derivatives
0.006 0.994 0.000
Z43.8 Attention to other artificial openings
0.006 0.994 0.000
Y52.7 Peripheral vasodilators
0.006 0.994 0.000
J33.9 Nasal polyp, unspecified
0.006 0.994 0.000
Y49.9 Psychotropic drug, unspecified
0.006 0.994 0.000
Y49.7 Psychostimulants with abuse potential
0.006 0.994 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.006 0.994 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.006 0.994 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.006 0.994 0.000
Y56.9 Topical agent, unspecified
0.006 0.994 0.000
Y56.8 Other topical agents
0.006 0.994 0.000
Y56.7 Dental drugs, topically applied
0.006 0.994 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.006 0.994 0.000
Y56.5 Ophthalmological drugs and preparations
0.006 0.994 0.000
Y56.2 Local astringents and local detergents
0.006 0.994 0.000
Y56.1 Antipruritics
0.006 0.994 0.000
Y46.8 Antispasticity drugs
0.006 0.994 0.000
Y46.3 Deoxybarbiturates
0.006 0.994 0.000
Y46.1 Oxazolidinediones
0.006 0.994 0.000
Y46.0 Succinimides
0.006 0.994 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.006 0.994 0.000
Y42.4 Oral contraceptives
0.006 0.994 0.000
Y46.7 Anti-Parkinsonism drugs
0.006 0.994 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
J36 Peritonsillar abscess
0.006 0.994 0.000
J32.9 Chronic sinusitis, unspecified
0.006 0.994 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.006 0.994 0.000
Y48.4 Anaesthetic, unspecified
0.006 0.994 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.005 0.994 0.000
A02.1 Salmonella septicaemia
0.005 0.994 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.006 0.994 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.005 0.994 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.005 0.994 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.005 0.994 0.000
Y47.4 Bromine compounds
0.005 0.994 0.000
Y47.3 Paraldehyde
0.005 0.994 0.000
Y47.2 Chloral derivatives
0.005 0.994 0.000
Y47.0 Barbiturates, not elsewhere classified
0.005 0.994 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.005 0.994 0.000
Y56.3 Emollients, demulcents and protectants
0.005 0.994 0.000
D73.4 Cyst of spleen
0.000 0.994 0.005
D73.2 Chronic congestive splenomegaly
0.000 0.995 0.005
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
Y46.6 Other and unspecified antiepileptics
0.005 0.995 0.000
Y41.5 Antiviral drugs
0.005 0.995 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
A08.3 Other viral enteritis
0.005 0.995 0.000
L93.1 Subacute cutaneous lupus erythematosus
0.000 0.995 0.005
Y41.0 Sulphonamides
0.005 0.995 0.000
Y50.9 Central nervous system stimulant, unspecified
0.005 0.995 0.000
Y50.8 Other central nervous system stimulants
0.005 0.995 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.005 0.995 0.000
Y50.1 Opioid receptor antagonists
0.005 0.995 0.000
Y50.0 Analeptics
0.005 0.995 0.000
Y58.9 Other and unspecified bacterial vaccines
0.005 0.995 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.005 0.995 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.005 0.995 0.000
Y58.5 Diphtheria vaccine
0.005 0.995 0.000
Y58.4 Tetanus vaccine
0.005 0.995 0.000
Y58.3 Plague vaccine
0.005 0.995 0.000
Y58.2 Cholera vaccine
0.005 0.995 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.005 0.995 0.000
Y58.0 BCG vaccine
0.005 0.995 0.000
Y55.4 Expectorants
0.005 0.995 0.000
Y59.0 Viral vaccines
0.005 0.995 0.000
Y59.9 Vaccine or biological substance, unspecified
0.005 0.995 0.000
Y59.8 Other specified vaccines and biological substances
0.005 0.995 0.000
Y59.2 Protozoal vaccines
0.005 0.995 0.000
Y59.1 Rickettsial vaccines
0.005 0.995 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.005 0.995 0.000
Y41.4 Anthelminthics
0.005 0.995 0.000
Y41.3 Other antiprotozoal drugs
0.005 0.995 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.005 0.995 0.000
Z43.2 Attention to ileostomy
0.005 0.995 0.000
J30.3 Other allergic rhinitis
0.005 0.995 0.000
Y49.2 Other and unspecified antidepressants
0.005 0.995 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.995 0.000
Y55.5 Anticommon cold drugs
0.005 0.995 0.000
Y55.3 Antitussives
0.005 0.995 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.005 0.995 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.005 0.995 0.000
Y55.0 Oxytocic drugs
0.005 0.995 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.005 0.995 0.000
Y41.1 Antimycobacterial drugs
0.005 0.995 0.000
Y59.3 Immunoglobulin
0.005 0.995 0.000
Y45.2 Propionic acid derivatives
0.005 0.995 0.000
Z43.0 Attention to tracheostomy
0.005 0.995 0.000
D73.5 Infarction of spleen
0.000 0.995 0.005
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
Y51.0 Anticholinesterase agents
0.005 0.995 0.000
J33 Nasal polyp
0.005 0.995 0.000
L93.2 Other local lupus erythematosus
0.000 0.995 0.005
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y48.5 Therapeutic gases
0.005 0.995 0.000
Y48.1 Parenteral anaesthetics
0.005 0.995 0.000
Y48.0 Inhaled anaesthetics
0.005 0.995 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.005 0.995 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
J37 Chronic laryngitis and laryngotracheitis
0.005 0.995 0.000
Z43.6 Attention to other artificial openings of urinary tract
0.005 0.995 0.000
B00.9 Herpesviral infection, unspecified
0.004 0.995 0.001
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
Z43.9 Attention to unspecified artificial opening
0.005 0.995 0.000
Z43.7 Attention to artificial vagina
0.005 0.995 0.000
Y45.8 Other analgesics and antipyretics
0.005 0.995 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.005 0.995 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.005 0.995 0.000
U89.8 Agent resistant to other single specified antibiotic
0.000 0.995 0.005
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
D73.8 Other diseases of spleen
0.000 0.995 0.004
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin
0.004 0.995 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.004 0.995 0.000
Y44.5 Thrombolytic drugs
0.004 0.996 0.001
Y43 Primarily systemic agents
0.004 0.996 0.000
Y45.4 Antirheumatics
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
Y45.5 4-Aminophenol derivatives
0.004 0.996 0.000
J33.1 Polypoid sinus degeneration
0.004 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.003 0.996 0.001
A02.0 Salmonella gastro-enteritis
0.004 0.996 0.000
Y48.3 Local anaesthetics
0.004 0.996 0.000
Z43.5 Attention to cyctostomy
0.004 0.996 0.000
J37.0 Chronic laryngitis
0.004 0.996 0.000
Z90.0 Acquired absence of part of head and neck
0.000 0.996 0.004
M46.46 Discitis, unspecified (Lumbar region)
0.004 0.996 0.000
J37.1 Chronic laryngotracheitis
0.003 0.996 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.996 0.000
Y43.2 Antineoplastic natural products
0.004 0.996 0.000
Y48.2 Other and unspecified general anaesthetics
0.003 0.996 0.000
Y57.5 X-ray contrast media
0.004 0.996 0.000
Y57.8 Other drugs and medicaments
0.003 0.996 0.000
Y57.7 Vitamins, not elsewhere classified
0.003 0.996 0.000
Y57.4 Pharmaceutical excipients
0.003 0.996 0.000
Y57.3 Alcohol deterrents
0.003 0.996 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.003 0.996 0.000
Y57.1 Lipotropic drugs
0.003 0.996 0.000
Y57.0 Appetite depressants [anorectics]
0.003 0.996 0.000
J32 Chronic sinusitis
0.004 0.996 0.000
Y43.4 Immunosuppressive agents
0.004 0.996 0.000
Y43.1 Antineoplastic antimetabolites
0.003 0.997 0.000
Y43.9 Primarily systemic agent, unspecified
0.003 0.997 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.003 0.997 0.000
Y43.6 Enzymes, not elsewhere classified
0.003 0.997 0.000
Y43.5 Acidifying and alkalising agents
0.003 0.997 0.000
M46.4 Discitis, unspecified
0.003 0.997 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.997 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.003 0.997 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.003 0.997 0.000
J38.2 Nodules of vocal cords
0.003 0.997 0.000
U89 Agent resistant to other and unspecified antibiotics
0.000 0.997 0.003
Y57.6 Other diagnostic agents
0.003 0.997 0.000
M46.42 Discitis, unspecified (Cervical region)
0.003 0.997 0.000
Y42.7 Androgens and anabolic congeners
0.001 0.997 0.002
Y43.0 Antiallergic and antiemetic drugs
0.003 0.997 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.003 0.997 0.000
M46.40 Discitis, unspecified (Multiple sites in spine)
0.003 0.997 0.000
M54.94 Dorsalgia, unspecified (Thoracic region)
0.000 0.997 0.003
N76.4 Abscess of vulva
0.003 0.997 0.000
M46.49 Discitis, unspecified (Site unspecified)
0.003 0.997 0.000
Z43.4 Attention to other artificial openings of digestive tract
0.003 0.997 0.000
S82.20 Fracture of shaft of tibia (closed)
0.003 0.997 0.000
M46.47 Discitis, unspecified (Lumbosacral region)
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.